Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy.
Wang S, Hao X, Dai L, Lou N, Fan G, Gao R, Yang M, Xing P, Liu Y, Wang L, Zhang Z, Yao J, Tang L, Shi Y, Han X.
Wang S, et al. Among authors: fan g.
Lung Cancer. 2024 Mar;189:107503. doi: 10.1016/j.lungcan.2024.107503. Epub 2024 Feb 9.
Lung Cancer. 2024.
PMID: 38359741